Investors purchased shares of Davita Inc (NYSE:DVA) on weakness during trading on Friday. $31.70 million flowed into the stock on the tick-up and $17.90 million flowed out of the stock on the tick-down, for a money net flow of $13.80 million into the stock. Of all companies tracked, Davita had the 20th highest net in-flow for the day. Davita traded down ($0.14) for the day and closed at $72.46
A number of research analysts have issued reports on the stock. SunTrust Banks restated a “hold” rating and issued a $80.00 target price on shares of Davita in a report on Wednesday, February 14th. Robert W. Baird set a $97.00 target price on shares of Davita and gave the company a “buy” rating in a report on Tuesday, February 13th. Bank of America restated a “buy” rating and issued a $92.00 target price (up from $85.00) on shares of Davita in a report on Thursday, January 11th. Zacks Investment Research upgraded shares of Davita from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 2nd. Finally, TheStreet upgraded shares of Davita from a “c” rating to a “b-” rating in a report on Thursday, January 4th. Two research analysts have rated the stock with a sell rating, five have given a hold rating, four have given a buy rating and two have assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $79.30.
The company has a market capitalization of $13,187.72, a price-to-earnings ratio of 21.06, a PEG ratio of 1.39 and a beta of 1.03. The company has a current ratio of 2.88, a quick ratio of 2.82 and a debt-to-equity ratio of 1.87.
Davita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, February 13th. The company reported $0.92 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.94 by ($0.02). The company had revenue of $2.78 billion for the quarter, compared to analysts’ expectations of $3.90 billion. Davita had a return on equity of 12.86% and a net margin of 4.65%. During the same quarter in the previous year, the company earned $0.98 earnings per share. equities analysts forecast that Davita Inc will post 4.15 earnings per share for the current fiscal year.
In other news, insider Charles Berg sold 7,048 shares of the stock in a transaction dated Monday, December 11th. The shares were sold at an average price of $69.24, for a total transaction of $488,003.52. Following the transaction, the insider now directly owns 5,359 shares in the company, valued at approximately $371,057.16. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider James K. Hilger sold 3,572 shares of the stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $78.95, for a total transaction of $282,009.40. Following the transaction, the insider now owns 33,649 shares in the company, valued at $2,656,588.55. The disclosure for this sale can be found here. Corporate insiders own 2.10% of the company’s stock.
Several hedge funds have recently made changes to their positions in DVA. OppenheimerFunds Inc. lifted its holdings in shares of Davita by 5,292.6% during the 4th quarter. OppenheimerFunds Inc. now owns 1,873,918 shares of the company’s stock worth $135,391,000 after acquiring an additional 1,839,168 shares during the period. Millennium Management LLC raised its holdings in Davita by 239.9% in the fourth quarter. Millennium Management LLC now owns 2,024,308 shares of the company’s stock valued at $146,256,000 after buying an additional 1,428,810 shares during the period. Bridger Management LLC purchased a new position in Davita in the fourth quarter valued at approximately $52,339,000. International Value Advisers LLC purchased a new position in Davita in the fourth quarter valued at approximately $45,175,000. Finally, Schroder Investment Management Group raised its holdings in Davita by 769.0% in the third quarter. Schroder Investment Management Group now owns 434,191 shares of the company’s stock valued at $25,387,000 after buying an additional 384,224 shares during the period. Institutional investors and hedge funds own 83.43% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Traders Buy Shares of Davita (DVA) on Weakness” was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this article on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://ledgergazette.com/2018/03/11/traders-buy-shares-of-davita-dva-on-weakness.html.
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.